Table of Contents Table of Contents
Previous Page  466 / 1096 Next Page
Information
Show Menu
Previous Page 466 / 1096 Next Page
Page Background

S451

ESTRO 36

_______________________________________________________________________________________________

Results

Left breast results: Identical coverage was achieved with

a D95 of 95.2% ±0.4 (DIBH) vs. D95= 95.4%±0.6

(FB)(p=0.27). No statistical difference were found in D98,

median and D2 (Figure1.A). Left lung results: No statistical

difference was also found (Figure1.B). Heart results: Doses

were significantly lower with DIBH; Dmean at 1.5Gy±0.8

(DIBH) vs. 2.9Gy±1.6 (FB) (p<0.001) and Dmax at

36.3Gy±14.7 (DIBH) vs. 46.2Gy±6.6 (FB) (p=0.004). DVH

metrics for V10, V20, V30, and V40 were all significantly

better in DIBH (Figure1.C). LAD coronary results: Doses

were significantly lower with DIBH with Dmean at 9.5Gy ±

7.2 (DIBH) vs. 21.8Gy±11.4 (FB) (p<0.001) and a Dmax at

29.2Gy±17 (DIBH) vs. 42.3Gy±12 (FB) (p=0.003). DVH

metrics favored the DIBH plans significantly all across the

range of doses (Figure.1D).

Conclusion

In the treatment left breast cancer, 3D-DIBH showed

superior dosimetric advantages in comparison to 3D-FB.

Both heart and LAD were significantly spared without

compromising left breast coverage. The LAD was spared

for doses ranging from the low dose spectrum to the

highest dose.

PO-0837 Dosimetric advantages afforded by Dynamic

WaveArc therapy accelerated partial breast irradiation

Y. Ono

1

, M. Yoshimura

1

, K. Hirata

1

, N. Mukumoto

1

, T.

Ono

1

, M. Inoue

1

, M. Ogura

1

, T. Mizowaki

1

, M. Hiraoka

2

1

Kyoto University- Graduate School of Medicine,

Department of Radiation Oncology and Image-applied

Therapy, Kyoto, Japan

2

Japanese Red Cross Wakayama Medical Center,

Department of Radiation Oncology, Wakayama, Japan

Purpose or Objective

We identify dosimetric advantages of the novel volumetric

modulated arc therapy (VMAT) featuring continuously

varying non-coplanar trajectories. This is the Dynamic

WaveArc (DWA) therapy used for accelerated partial

breast irradiation (APBI). The dose distribution of DWA

therapy was compared to that of non-coplanar three-

dimensional conformal radiotherapy (3D-CRT) and

coplanar VMAT.

Material and Methods

We evaluated APBI dose distributions, delivered via DWA,

in 24 left-side breast cancer patients via non-coplanar 3D-

CRT from November 2011 to April 2016 at our institution.

The prescribed dose was 38.5 Gy in 10 fractions. The

Vero4DRT enables DWA by continuous gantry rotation and

O-ring skewing with moving dynamic multi-leaf collimator

(MLC). Thus, the Vero4DRT delivers non-coplanar VMAT

without couch rotation, minimizing dose delivery to

adjacent organs at risk (OARs). We created two sets of 11

control points (at angles 315-35° to the O-ring angle, and

110-155° and 290-355° to the gantry angle), for two non-

coplanar DWA trajectories. DWA, non-coplanar 3D-CRT,

and coplanar VMAT treatment plans were created by a

clinical treatment planning system, Raystation, using a

collapsed cone dose-calculation algorithm (Figure 1-A).

The mean DWA doses to the planning target volume (PTV),

the bilateral breasts, the lungs, the heart, the left

anterior descending artery (LAD), and the thyroid, were

compared to those of non-coplanar 3D-CRT and coplanar

VMAT. A p value < 0.05, derived using the paired Student’s

t-test, was considered to reflect a significant difference.

Results

Figure 1-B shows the averaged dose-volume histograms for

all 24 patients in terms of their PTVs and OARs. The Table

summarizes the mean dose volume indices for the targets

and OARs, and the MU for each technique. Significant

difference was not observed in doses to the PTV. When

DWA was employed, the average V

20Gy

, V

10Gy

, and V

5Gy

to

the ipsilateral lung; the average V

10Gy

and V

5Gy

to the heart;

the D

2%

for the planning organ at risk volume of the LAD

(PRV_LAD); and the V

50%

of, and the mean dose to the

ipsilateral breast, were significantly lower than those of

non-coplanar 3D-CRT and coplanar VMAT. The average D

2%

to the contralateral breast and the V

5Gy

to the

contralateral lung did not differ significantly among the

techniques. Furthermore, the mean prescribed MU for

DWA was 486.22 MU, which was only 9.8% higher than that

for non-coplanar 3D-CRT (442.67 MU) (p < 0.05).